Global Blood Therapeutics Inc (NASDAQ:GBT)

54.19
Delayed Data
As of Sep 25
 +0.84 / +1.57%
Today’s Change
39.95
Today|||52-Week Range
87.54
-31.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization873.0K1.2M1.7M4.6M
 
 
 
 
 
 
Operating ExpensesGross Income-873.0K-1.2M-1.7M-4.6M
 
 
 
 
 
General Expenses45.5M81.9M117.6M178.1M
 
 
 
 
 
Research And Development36.7M61.2M87.8M131.3M
 
 
 
 
 
Total Operating Expenses46.4M83.1M119.2M182.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.4M-83.1M-119.2M-182.7M
 
 
 
 
 
Other Expenses0.00659.0K-334.0K-69.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.4M-82.5M-117.0M-174.2M
 
 
 
 
 
Preferred Dividend-4.2M0.000.000.00
 
 
Net Income-46.4M-82.5M-117.0M-174.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M33.2M42.3M51.2M
 
 
 
 
 
Shares To Calculate EPS Diluted12.8M33.2M42.3M51.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.95-$2.48-$2.76-$3.41
 
 
 
 
 
EPS Diluted-$3.95-$2.48-$2.76-$3.41